Welcome to LookChem.com Sign In|Join Free
  • or
Benzo[b]thiophen-4(5H)-one, 2-chloro-6,7-dihydro- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

22168-07-6

Post Buying Request

22168-07-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

22168-07-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 22168-07-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,1,6 and 8 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 22168-07:
(7*2)+(6*2)+(5*1)+(4*6)+(3*8)+(2*0)+(1*7)=86
86 % 10 = 6
So 22168-07-6 is a valid CAS Registry Number.

22168-07-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-chloro-6,7-dihydro-5H-1-benzothiophen-4-one

1.2 Other means of identification

Product number -
Other names 2-Chloro-6,7-dihydrobenzo[b]thiophen-4(5H)-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:22168-07-6 SDS

22168-07-6Downstream Products

22168-07-6Relevant academic research and scientific papers

ARYLAMIDES AND METHODS OF USE THEREOF

-

Page/Page column 108, (2021/06/11)

The present disclosure relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.

p-diaminobenzene derivative as potassium channel regulator, preparation method and medical applications thereof

-

Paragraph 0346-0350; 0421-0425, (2019/12/09)

The invention relates to a p-diaminobenzene derivative as a potassium channel regulator, a preparation method and medical applications thereof, and specifically discloses a compound represented by a general formula A or a pharmaceutically acceptable salt

Pharmaceutical compounds

-

Page/Page column 9, (2008/06/13)

Tricyclic pyrazole derivatives of the following formula (I) having affinity for the cannabinoidergic CB1 and/or CB2 receptors: wherein: A represents a group selected from one of the following: (CH2)t—, —(CH2)—S(O)z/s

Tricyclic pyrazole derivatives as cannabinoid receptor antagonists

-

Page/Page column 13, (2010/02/14)

Tricyclic pyrazole derivatives of the following formula (I) having affinity for the cannabinoidergic CB1 and/or CB2 receptors: wherein:A represents a group selected from one of the following:(CH2)t-, -(CH2)-S(O)z/sub

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 22168-07-6